Logo image of LAB.CA

LABRADOR GOLD CORP (LAB.CA) Stock Fundamental Analysis

Canada - TSX-V:LAB - CA50543R1091 - Common Stock

0.11 CAD
0 (0%)
Last: 10/30/2025, 7:00:00 PM
Fundamental Rating

2

LAB gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 805 industry peers in the Metals & Mining industry. No worries on liquidiy or solvency for LAB as it has an excellent financial health rating, but there are worries on the profitability. LAB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year LAB has reported negative net income.
In the past year LAB has reported a negative cash flow from operations.
In the past 5 years LAB always reported negative net income.
In the past 5 years LAB always reported negative operating cash flow.
LAB.CA Yearly Net Income VS EBIT VS OCF VS FCFLAB.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

Looking at the Return On Assets, with a value of -96.28%, LAB is doing worse than 73.91% of the companies in the same industry.
LAB's Return On Equity of -97.23% is on the low side compared to the rest of the industry. LAB is outperformed by 64.97% of its industry peers.
Industry RankSector Rank
ROA -96.28%
ROE -97.23%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LAB.CA Yearly ROA, ROE, ROICLAB.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5 -10 -15 -20

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for LAB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LAB.CA Yearly Profit, Operating, Gross MarginsLAB.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

8

2. Health

2.1 Basic Checks

LAB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LAB.CA Yearly Shares OutstandingLAB.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M
LAB.CA Yearly Total Debt VS Total AssetsLAB.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

LAB has an Altman-Z score of 44.94. This indicates that LAB is financially healthy and has little risk of bankruptcy at the moment.
LAB has a better Altman-Z score (44.94) than 82.11% of its industry peers.
LAB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 44.94
ROIC/WACCN/A
WACCN/A
LAB.CA Yearly LT Debt VS Equity VS FCFLAB.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

LAB has a Current Ratio of 74.76. This indicates that LAB is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of LAB (74.76) is better than 98.14% of its industry peers.
A Quick Ratio of 74.76 indicates that LAB has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 74.76, LAB belongs to the best of the industry, outperforming 98.14% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 74.76
Quick Ratio 74.76
LAB.CA Yearly Current Assets VS Current LiabilitesLAB.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for LAB have decreased strongly by -4576.67% in the last year.
EPS 1Y (TTM)-4576.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LAB.CA Yearly EPS VS EstimatesLAB.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 -0 -0 -0.01 -0.01 -0.01

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

LAB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LAB.CA Price Earnings VS Forward Price EarningsLAB.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LAB.CA Per share dataLAB.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LAB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LABRADOR GOLD CORP

TSX-V:LAB (10/30/2025, 7:00:00 PM)

0.11

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)01-26 2026-01-26
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners2.66%
Ins Owner ChangeN/A
Market Cap18.70M
Revenue(TTM)N/A
Net Income(TTM)-23851900
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.76
P/tB 0.76
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.14
TBVpS0.14
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -96.28%
ROE -97.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 16444.4%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 74.76
Quick Ratio 74.76
Altman-Z 44.94
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)73351%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4576.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y35.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y94.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y81.83%
OCF growth 3YN/A
OCF growth 5YN/A

LABRADOR GOLD CORP / LAB.CA FAQ

What is the ChartMill fundamental rating of LABRADOR GOLD CORP (LAB.CA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to LAB.CA.


What is the valuation status for LAB stock?

ChartMill assigns a valuation rating of 0 / 10 to LABRADOR GOLD CORP (LAB.CA). This can be considered as Overvalued.


Can you provide the profitability details for LABRADOR GOLD CORP?

LABRADOR GOLD CORP (LAB.CA) has a profitability rating of 0 / 10.